 |
PREJUVA®
PREJUVA® constitutes a buffered physiological solution of high molecular weight (H-HA) and low molecular weight (L-HA) HA.
the H-HA and L-HA chains, they interact with each other providing unique rheological characteristics and thus allowing the administration of higher concentrations of HA without increasing the viscosity.
The formulation of HA with different molecular weights contained in PREJUVA® is aimed at counteracting the physiological reduction of HA in the skin, restoring hydration, elasticity and skin tone, by associating, in a synergic way, deep hydration with the mechanical action of lifting the skin.
PREJUVA® is indicated for treatment of the face and body. It is particularly indicated for treatment of the malar-zygomatic(cheek bone areas) and submalar areas. An initial cycle of two treatment sessions at 30 day intervals is recommended, followed if necessary by maintenance treatments every 2 months.
What is Prejuva?
Prejuva muscle base cell activation course injection, commonly known as hyaluronic acid counterclockwise; Manufactured in Italy by IBSA Pharmaceutical, Switzerland, it is an FDA-approved pharmaceutical grade hyaluronic acid manufacturer. Prejuva is characterized by a mixture of high molecular weight and low molecular weight hyaluronic acid; Thicker and slow-metabolizing polymer hyaluronic acid is injected into the 5-point facial position according to the aesthetic principle to establish a long-lasting dermis layer scaffold, support the loose skin, stimulate the regeneration of collagen and elastin at the injection site, and assist in achieving the lifting effect; simultaneous use of low molecular weight hyaluronic acid, Spread evenly over the face to achieve the effect of facial hydration. And through heat energy cross-linking, without cross-linking agent BDDE, it can reshape and firm facial skin and moisturize facial cells.
What is PREJUVA?
PREJUVA® constitutes a buffered physiological solution of high molecular weight (H-HA) and low molecular weight (L-HA) HA. The HA, at both high and low molecular weights used in the device, is obtained through a biofermentation process without chemical modification and therefore, resulting in excellent tolerability.
Furthermore, due to a specific and patented treatment of the solution (HYLAFUSE Technology TM), the H-HA and L-HA chains, contained in PREJUVA®, interact with each other providing unique rheological characteristics and thus allowing the administration of higher concentrations of HA without increasing the viscosity.
Dermax Co., Ltd. is a biotechnology enterprise specialized in the research, production and sale of aesthetic products. The establishment of professional technical team, GMP production plant, complete and strict testing system has guaranteed stable and advanced manufacturing technique. The high quality, integrity and global marketing network enable our company to win high praise home and abroad including in Europe, America, Southeast Asia etc.
PREJUVA® constitutes a buffered physiological solution of high molecular weight (H-HA) and low molecular weight (L-HA) HA.
the H-HA and L-HA chains, they interact with each other providing unique rheological characteristics and thus allowing the administration of higher concentrations of HA without increasing the viscosity.
The formulation of HA with different molecular weights contained in PREJUVA® is aimed at counteracting the physiological reduction of HA in the skin, restoring hydration, elasticity and skin tone, by associating, in a synergic way, deep hydration with the mechanical action of lifting the skin.
PREJUVA® is indicated for treatment of the face and body. It is particularly indicated for treatment of the malar-zygomatic(cheek bone areas) and submalar areas. An initial cycle of two treatment sessions at 30 day intervals is recommended, followed if necessary by maintenance treatments every 2 months.
What is Prejuva?
Prejuva muscle base cell activation course injection, commonly known as hyaluronic acid counterclockwise; Manufactured in Italy by IBSA Pharmaceutical, Switzerland, it is an FDA-approved pharmaceutical grade hyaluronic acid manufacturer. Prejuva is characterized by a mixture of high molecular weight and low molecular weight hyaluronic acid; Thicker and slow-metabolizing polymer hyaluronic acid is injected into the 5-point facial position according to the aesthetic principle to establish a long-lasting dermis layer scaffold, support the loose skin, stimulate the regeneration of collagen and elastin at the injection site, and assist in achieving the lifting effect; simultaneous use of low molecular weight hyaluronic acid, Spread evenly over the face to achieve the effect of facial hydration. And through heat energy cross-linking, without cross-linking agent BDDE, it can reshape and firm facial skin and moisturize facial cells.
What is PREJUVA?
PREJUVA® constitutes a buffered physiological solution of high molecular weight (H-HA) and low molecular weight (L-HA) HA. The HA, at both high and low molecular weights used in the device, is obtained through a biofermentation process without chemical modification and therefore, resulting in excellent tolerability.
Furthermore, due to a specific and patented treatment of the solution (HYLAFUSE Technology TM), the H-HA and L-HA chains, contained in PREJUVA®, interact with each other providing unique rheological characteristics and thus allowing the administration of higher concentrations of HA without increasing the viscosity.
Dermax Co., Ltd. is a biotechnology enterprise specialized in the research, production and sale of aesthetic products. The establishment of professional technical team, GMP production plant, complete and strict testing system has guaranteed stable and advanced manufacturing technique. The high quality, integrity and global marketing network enable our company to win high praise home and abroad including in Europe, America, Southeast Asia etc.
